Showing results (1-10 of 496) with videos related to
Sort By:
Pageof 50
BMC Biology|April 14, 2010
Biology-driven cancer drug development: back to the futureChristopher J Lord, Alan AshworthCurrent Opinion in Pharmacology|July 23, 2008
Targeted therapy for cancer using PARP inhibitorsChristopher J Lord, Alan AshworthScience (New York, N.Y.)|March 18, 2017
PARP inhibitors: Synthetic lethality in the clinicChristopher J Lord, Alan AshworthNature Medicine|November 9, 2013
Mechanisms of resistance to therapies targeting BRCA-mutant cancersChristopher J Lord, Alan AshworthNature Reviews. Clinical Oncology|June 30, 2018
Synthetic lethal therapies for cancer: what's next after PARP inhibitors?Alan Ashworth, Christopher J LordClinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2009
Bringing DNA repair in tumors into focusChristopher J Lord, Alan AshworthCritical Reviews in Oncology/Hematology|December 10, 2016
PARP inhibitor combination therapyAmy Dréan, Christopher J Lord, Alan AshworthCell Cycle (Georgetown, Tex.)|July 8, 2008
Dissecting resistance to endocrine therapy in breast cancerChristopher J Lord, Elizabeth Iorns, Alan AshworthPageof 50